Inventor
HOLLY KORDASIEWICZ
Inventor
US
Overview
Patents· 11 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Nprimary
C12NMicroorganisms or enzymes29%
A61KPreparations for medical, dental or toiletry purposes26%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations26%
C07HSugars16%
C12YEnzymes3%
PatentTitleYear
12,529,055Methods and compositions for inhibiting PMP22 expression202612,350,285Compounds and methods for reducing ATXN3 expression202512,297,431Modulation of huntingtin expression202512,091,662Compositions for modulating tau expression202411,959,080Methods and compositions for inhibiting PMP22 expression202411,591,595Compositions for modulating Tau expression202311,530,411Methods for reducing LRRK2 expression202211,492,615Antisense compounds and uses thereof202211,421,231Modulation of Huntington expression202211,230,712Compounds and methods for reducing SNCA expression202211,136,577Methods and compositions for inhibiting PMP22 expression2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2026Patents assigned to IONIS PHARMACEUTICALS INC (9)· patent assignee history
2021–2026Based in US· patent location history
2023–2024Patents assigned to BIOGEN MA INC (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| IONIS PHARMACEUTICALS INC | 9 | 2021–2026 |
| BIOGEN MA INC | 2 | 2023–2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 11 | 2021–2026 |